CClinicalTrials.gg
CompletedNCT07180329Updated Sep 18, 2025

Zinc and Selenium Bioactivity

An interventional study of Myrin P Fort and Zn + Se supplemented cookies in Immunomodulatory Drugs and Tuberculosis, sponsored by University of Lahore. Completed at 1 site in Pakistan. Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-09-18.

Sponsored by University of Lahore · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Feb 2023, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
30 Years to 55 Years
Sex
All
01

Study summary

The primary hypothesis of the study was that zinc and selenium supplementation through fortified cookies would enhance the immune response and improve clinical outcomes in tuberculosis patients. For this purpose, a single-blind randomized control trial was carried out to determine the effect of zinc and selenium on the immunomodulatory parameters of tuberculosis approved by the Ethics Committee of the University of Lahore, Pakistan. In the first phase, the proximate and minerals profile of shiitake mushroom was analyzed, and functional cookies were developed fortified with zinc and selenium. In the second phase, 120 tuberculosis patients were divided into four groups (T0, T1, T2 \& T3) to assess the impact of supplementation on anthropometric, microbiological, and hematological parameters. Meanwhile, results were statistically examined through Principal component analysis and a heat map of the attributes under research were generated using R-studio (Version 4.2.2). However, results explained that the therapeutic effect of dosage on anthropometric, microbiological, and hematological measurements showed a significant result (p≤0.05), indicating that zinc and selenium may help to modulate the immunological response, and potentially improving the body's ability to resist tuberculosis.

Read the detailed description

2. Materials and methods 2.1. Procurement of raw materials Shiitake was procured from the departmental store of Lahore and placed in a sealed bag (Zip bag). All the research work was performed at the University of Lahore's Institute of Food Science and Technology

2.2. Fortification of Zn and Se in the rice flour cookies Cookies were made with rice flour samples supplemented with Zn and Se extracted from shiitake mushroom, at concentrations of 100, 150, and 200 mg/kg of cookie dough, according to the usual process outlined by AACC. Butter, sugar, salt, baking powder, egg, ghee and water were used as common ingredients in all treatments, while Zn, and Se extracted from shiitake powder were used as variable ingredients according to the treatments plan given in ST 1. All ingredients were weighed precisely and mixed homogeneously in laboratory mixer bowl for 10 minutes for each treatment group (T0, T1, T2 and T3). After the homogenous mixing, a resting period of 10 to 15 minutes was applied. The dough was converted into a 5mm thick sheet which was cut into cookies using suitable molds. Baking was accomplished at 170°C for 12 to 15 minutes followed by cooling at room temperature. After cooling, cookies were packed in propylene bags. However, each serving (one cookie) in groups T1, T2, and T3 provided an average of 10 mg:10 µg, 15 mg:15 µg, and 20 mg:20 µg of Zn and Se, respectively, as verified by formulation and batch testing. All batches were processed under standardized conditions to ensure ingredient homogeneity and batch to batch uniformity.

Anthropometric measurements, Microbiological and Hematological Parameters were measured 2.4. Statistical Analysis All resulting data were analyzed statistically to test the significance level (p≤0.05) via the completely randomized design (CRD) by using analytical software statistix (version 8.1).

02

Conditions studied

  • Immunomodulatory Drugs
  • Tuberculosis

Browse trials for

Keywords

  • Nutrition
  • tuberculosis
  • immunomodulatory
  • mushrooms
  • fortified
03

In context

Tuberculosis

1,417 studies on the registry are indexed under Tuberculosis; 208 are open to participants now.

This study's enrollment of 90 is below the median of 150 across 952 interventional studies indexed under Tuberculosis.

Browse Tuberculosis studies →

Lead sponsor

University of Lahore is the lead sponsor of 223 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 30-55 years.
  • Confirmed diagnosis of pulmonary tuberculosis (Pul-TB) with positive acid-fast bacilli (AFB) in sputum samples.

Exclusion criteria

Exclusion Criteria

  • Patients diagnosed with extra-pulmonary TB.
  • Patients who had been on anti-TB therapy for more than 2 months prior to enrollment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Placebo comparator
    Control group

    Patients took Myrin P Fort

    Dietary Supplement: Myrin P Fort

  • Experimental
    Zn + Se supplemented cookies

    patients took Zn + Se supplemented cookies

    Dietary Supplement: Zn + Se + Myrin P Fort

  • Experimental
    Zn + Se + Myrin P Fort

    Patients took Zn + Se \+ Myrin P Fort

    Dietary Supplement: Zn + Se supplemented cookies

Interventions

  • Dietary supplementMyrin P Fort

    Patient took Myrin P Fort

  • Dietary supplementZn + Se supplemented cookies

    patients took Zn + Se supplemented cookies

  • Dietary supplementZn + Se + Myrin P Fort

    patients took Zn + Se \+ Myrin P Fort

06

What researchers measure

Primary outcomes

  1. Anthropometric measurements

    Body Mass Index was measured. The formula for Body Mass Index (BMI) is: kg/m\^2.

    Time frame: 5 months

  2. Determination of MAC, MAMC, and TSF

    The anthropometric measurements of the patients were assessed, including Mid-Arm Circumference (MAC, cm), Mid-Arm Muscle Circumference (MAMC, cm), and Triceps Skinfold Thickness (TSF, mm). These parameters were measured to evaluate the nutritional and muscle status of the patients

    Time frame: 5 months

Secondary outcomes

  1. Hematological analysis

    Hematological analyses were performed, including hemoglobin concentration (g/dL)

    Time frame: 5 months

07

Study locations

1 site
  • Sana Noreen
    Lahore, 54000, Pakistan
08

References and documents

Publications

  • Mughal H, Tufail T, Ain HBU, Rasheed A, Alum EU. Immunomodulatory Effects of Zinc and Selenium-Enriched Lentinula edodes Extract: Biochemical Characterization and Bioactivity Relevant to Tuberculosis. Food Sci Nutr. 2026 Apr 8;14(4):e71736. doi: 10.1002/fsn3.71736. eCollection 2026 Apr. PubMed 41971609 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07180329
Lead sponsor
University of Lahore
Responsible party
Sana Noreen (Assistant Professor, University of Lahore) — Principal investigator
First posted
Sep 18, 2025
Start date
Feb 1, 2023
Primary completion
Jul 25, 2023
Completion
Jul 25, 2023
Last update
Sep 18, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion